Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice.

Saved in:
Bibliographic Details
Title: Self-adjuvanting nanovaccines boost lung-resident CD4+ T cell immune responses in BCG-primed mice.
Authors: Files MA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Institute of Translational Science, University of Texas Medical Branch, Galveston, TX, 77555, USA., Naqvi KF; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA., Saito TB; Department of Pathology, University of Texas Medical Branch, Galveston, TX, 77555, USA.; Laboratory of Bacteriology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA., Clover TM; Comprehensive Industrial Hygiene Laboratory (CIHL), Navy Environmental and Preventive Medicine Unit TWO (NEPMU-2), Department of the Navy, Norfolk, VA, 23551, USA., Rudra JS; Department of Biomedical Engineering, McKelvey School of Engineering, Washington University in St. Louis, St. Louis, MO, 63130, USA. srudra22@wustl.edu., Endsley JJ; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA. jjendsle@utmb.edu.
Source: NPJ vaccines [NPJ Vaccines] 2022 Apr 26; Vol. 7 (1), pp. 48. Date of Electronic Publication: 2022 Apr 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-022-00466-0